RHUMALGAN K 50 mg price in UAE

Overview

Welcome to Dwaey, specifically on RHUMALGAN K 50 mg Powder for Oral Solution page.
This medicine contains an important and useful components, as it consists of Diclofenac potassium.
RHUMALGAN K 50 mg is available in the market in concentration 50 mg/Sachet and in the form of Powder for Oral Solution.

LAGAP SA is the producer of RHUMALGAN K 50 mg and it is imported from UAE, The most popular alternatives of RHUMALGAN K 50 mg are listed downward .

Mode Of Action

Diclofenac, a phenylacetic acid derivative is a prototypical NSAID. It has potent anti-inflammatory, analgesic and antipyretic actions. It reversibly inhibits the enzyme, cyclooxygenase, thus resulting in reduced synthesis of prostaglandin precursors.

Indication

Rheumatoid arthritis
Osteoarthritis
Ankylosing spondylitis
Pain
Migraine
Allergic conjunctivitis
Dysmenorrhea
Muscle aches
Acute gout
Inflammation
Renal colic
Miosis
Tendinitis
Actinic keratosis
Backaches
Dental pain
Menstrual cramps
Bursitis

Precaution

History of GI ulceration; impaired cardiac, renal or hepatic function; hypertension; lactation. IV admin in patients with moderate or severe renal impairment; hypovolaemia or dehydration; asthma, porphyria. Monitor LFTs in patients on prolonged therapy. May prolong bleeding time; caution when used in patients with coagulation disorders or on anticoagulants. Prolonged therapy may increase risk of anaemia. 1st and 2nd trimester of pregnancy. Elderly, debilitated patients. Lactation: Excreted in breast milk; not recommended

Side Effects

Side-effects of Diclofenac is usually mild and transient. It is generally well tolerated. At the starting of the treatment
however
patients may sometimes complain of gastrointestinal discomfort
epigastria pain
eructation
nausea and Diarrhoea
headache and bleeding sometime may occur. Occasionally skin rash
peripheral oedema and abnormalities of serum transaminase have been reported.Very rarely reported side effects include activation of peptic ulcer
haematemesis or melena
blood dyscrasia (extensive usage). There have been isolated reports of anaphylactoid reactions.

Contra indication

It is contra-indicated for those patients who are hypersensitive to Diclofenac. In patients with active or suspected peptic ulcer or gastrointestinal bleeding, or for those patients in whom attacks of asthma, urticaria or acute rhinitis are precipitated by aspirin or other NSAIDs possessing prostaglandin synthetase inhibitinig activity, it is also contraindicated.

Pregnancy and lactation

Pregnancy category: C

Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks

Pregnancy category: C; avoid use in late pregnancy (may cause premature closure of ductus arteriosus); category D if >30 weeks after gestation

Interaction

May increase serum levels of methotrexate. Concomitant use w/ other NSAIDs or anticoagulants (e.g. warfarin) is associated w/ higher risk of GI bleeding. Increased risk of nephrotoxicity w/ ciclosporin or triamterene. May increase the risk of developing corneal complications in patients w/ significant pre-existing corneal inflammation when use concomitantly w/ ophth preparation containing corticosteroids. Colestyramine and colestipol reduce the bioavailability of diclofenac. Decreased plasma concentration when administered after sucralfate. Ophth application of diclofenac may reduce the efficacy of ophth acetylcholine and carbachol. May increase serum levels of lithium and digoxin.